Syntis Bio
ID: 17839704Syntis Bio is a Boston-based biotech (founded 2025 by MIT’s Langer, Traverso & team) developing oral therapies targeting metabolic control in the small intestine.
1
Funding Rounds
$38.0m
Money raised
Recent Funding Rounds
Overview
Syntis Bio is a Boston-based biotech (founded 2025 by MIT’s Langer, Traverso & team) developing oral therapies targeting metabolic control in the small intestine.
- Website:
- Business model: UNKNOWN
- Headquarters: Boston
- Social accounts: linkedin
Unlock Complete Company Intelligence
Access comprehensive data and insights available only to Seedtable members
Financial Details
- • Complete funding history and valuations
- • Revenue estimates and financial metrics
- • Investment round details and terms
People & Contacts
- • Complete leadership team profiles
- • Contact information and email addresses
- • Board members and advisors
Market Intelligence
- • Competitive landscape analysis
- • Market position and growth metrics
- • Industry benchmarking data
Premium Tools
- • Export data and generate reports
- • Save companies to custom watchlists
- • API access for data integration
Join 10,000+ Professionals
Trusted by investors, founders, and analysts worldwide
Access detailed insights on 71,000+ companies worldwide
| Name | Phone | Social networks | |
|---|---|---|---|
| Ra*** Dh**** |
|
- | - |
| Ro**** La**** | - | - | |
| Gi****** Tr****** | - | - |